Biogen
Biogen
Biogen (pronounced: /ˈbaɪoʊdʒɛn/) is an American multinational biotechnology company based in Cambridge, Massachusetts. The company specializes in the discovery, development, and delivery of therapies for the treatment of neurodegenerative diseases, hemophilia, and autoimmune disorders.
Etymology
The name "Biogen" is a portmanteau of the words "biological" and "generation", reflecting the company's focus on genetic engineering and its application in the field of medicine.
History
Biogen was founded in 1978 by several prominent biologists, including Nobel Prize laureates Walter Gilbert and Phillip Sharp. The company has since grown to become one of the world's leading biotechnology companies, with a diverse portfolio of therapies for various diseases.
Products and Services
Biogen's product portfolio includes treatments for multiple sclerosis, such as Tecfidera and Tysabri, as well as Spinraza, a treatment for spinal muscular atrophy. The company also offers services in drug discovery, clinical development, and commercialization of novel therapeutics.
Related Terms
- Biotechnology
- Neurodegenerative diseases
- Hemophilia
- Autoimmune disorders
- Genetic engineering
- Nobel Prize
- Walter Gilbert
- Phillip Sharp
- Tecfidera
- Tysabri
- Spinraza
- Drug discovery
- Clinical development
- Commercialization
This WikiMD.org article is a stub. You can help make it a full article.